In Vivo Uptake of Chitosan Microparticles by Murine Peyer's Patches: Visualization Studies using Confocal Laser Scanning Microscopy and Immunohistochemistry

Although oral vaccination has numerous advantages over parenteral injection, degradation of the vaccine and low uptake by the gut associated lymphoid tissue (GALT) still complicate the development of efficient oral vaccines. However, previous studies in our laboratory demonstrated that chitosan microparticles can have suitable size, charge, loading and release characteristics for oral vaccination using ovalbumin as model vaccine. In this study, two different approaches were used to investigate the in vivo uptake of chitosan microparticles by murine Peyer's patches. Firstly, a confocal laser scanning microscopy (CLSM) study was performed to visualize the uptake of fluorescent-labeled chitosan microparticles in the Peyer's patches after intragastrical feeding. Subsequently, the intestinal epithelial uptake of ovalbumin loaded chitosan microparticles was visualized using immunohistochemical staining of ovalbumin. Because the microparticles are biodegradable, this entrapped ovalbumin will be released after intracellular digestion in the Peyer's patches. CLSM visualization demonstrated that chitosan microparticles enhance the uptake of fluorescent-labeled ovalbumin by the epithelium of the Peyer's patches. No ovalbumin uptake by the intestinal epithelium was observed when the protein was administered without microparticles. Moreover, immunohistochemical visualization studies revealed that ovalbumin could only be transported into the Peyer's patches after association to chitosan microparticles. Since uptake by Peyer's patches is an essential step in oral vaccination, these in vivo experiments demonstrate that chitosan microparticles are very promising vaccine delivery systems.

[1]  G. Dougan,et al.  Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin , 1997, Infection and immunity.

[2]  C. Ruedl,et al.  Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens. , 1997, International archives of allergy and immunology.

[3]  D. McCarthy,et al.  Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose , 1992 .

[4]  A. Pfeifer,et al.  Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres. , 2000, Vaccine.

[5]  J L Pedraz,et al.  Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[6]  M. Suckow,et al.  Oral vaccination of animals with antigens encapsulated in alginate microspheres. , 1999, Vaccine.

[7]  C. Partidos,et al.  Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[8]  H. Greenberg,et al.  Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. , 1999, Virology.

[9]  M. Alonso,et al.  Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .

[10]  D. Cremaschi,et al.  Selective transport of microparticles across Peyer's patch follicle‐associated M cells from mice and rats , 1995, Experimental physiology.

[11]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .

[12]  Manmohan J. Singh,et al.  Advances in vaccine adjuvants , 1999, Nature Biotechnology.

[13]  D. O'hagan,et al.  Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. , 1994, Immunology.

[14]  M. Jang,et al.  Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles. , 1999, Vaccine.